
Sarah Murawski, MPAS, discusses how telemedicine can impact the use of chimeric antigen receptor T-cell therapy in patients with cancer at the Association of Community Cancer Centers National Oncology Conference.

Your AI-Trained Oncology Knowledge Connection!


Published: November 27th 2019 | Updated: